Skip to content

Candel Therapeutics, Inc.

CADL· NasdaqCore metricsCIK 1841387

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -8.90%
Market cap
$658.16M
78.45M shares
Filings
423
$125.00K
FY 2022±0.0% FY22 yoy
-$21.87M
Q3 2026N/M FY25 yoy
-$22.98M
Q3 2026N/M FY25 yoy
-$59.22M
Q3 2026derivedN/M FY25 yoy
-$0.28
Q3 2026N/M FY25 yoy
$203.12M
Q3 2026+16.6% FY25 yoy
$658.16M
—
—
5.0×
-5.91%
—

FY2025 figures · derived

Price

$8.39+67.13%+$3.37past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$125.00KFY 2022
$125.00K0FY 2020FY 2021FY 2022
PeriodEndedValueKindSource trail
FY 20222022-12-31$125,000reported
FY 20212021-12-31$125,000reported
FY 20202020-12-31$125,000reported

Biological products, except diagnostic substances

Candel Therapeutics, Inc. is the 57th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Candel Therapeutics, Inc. · CIK 1841387 · Engraved from SEC EDGAR